CSIMarket Company Name, Ticker, Suppliers, else..


Cytomx Therapeutics Inc   (NASDAQ: CTMX)
Other Ticker:  
 

Cytomx Therapeutics Inc

CTMX's Fundamental analysis



Cytomx Therapeutics Inc 's sales fell by -82.16 % in the third quarter of 2025 from the same quarter a year ago.

Major Pharmaceutical Preparations industry recorded growth of revenues by 9.16 %

Cytomx Therapeutics Inc faced net loss in contrast to the net income a year ago in third quarter of 2025

• More on CTMX's Growth


Cytomx Therapeutics Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Cytomx Therapeutics Inc PEG ratio is at 0.08 Cytomx Therapeutics Inc realized cash reduction of $ -0.04 per share in trailing twelve-month period.
Company
10.11
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 5.71.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.86.


• More on CTMX's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 946,925
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 53.12
 Tangible Book Value (Per Share $) 0.64

Cytomx Therapeutics Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Cytomx Therapeutics Inc PEG ratio is at 0.08 Cytomx Therapeutics Inc realized cash outflow of $ -0.04per share in trailing twelve-month period.
Company
10.11
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 5.71.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.86.

Cytomx Therapeutics Inc Price to Book Ratio is at 6.04 lower than Industry Avg. of 105.06. and higher than S&P 500 Avg. of 0.02

• More on CTMX's Valuation

•  Market Capitalization (Millions $) 648
•  Shares Outstanding (Millions) 165
•  Employees 120
•  Revenues (TTM) (Millions $) 114
•  Net Income (TTM) (Millions $) 28
•  Cash Flow (TTM) (Millions $) -6
•  Capital Exp. (TTM) (Millions $) -
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 946,925
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 53.12
•  Tangible Book Value (Per Share $) 0.64

•  Market Capitalization (Millions $) 648
•  Shares Outstanding (Millions) 165
•  Employees 120
•  Revenues (TTM) (Millions $) 114
•  Net Income (TTM) (Millions $) 28
•  Cash Flow (TTM) (Millions $) -6
•  Capital Exp. (TTM) (Millions $) -





  Ratio
•   Capital Ratio (MRQ) 3.64
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.48
•  Asset Turnover Ratio (TTM) 0.82
•  Inventory Turnover Ratio (TTM) -





Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.